# ADAPT - A Patient Registry of the Real-world Use of Orenitram®

> **NCT03045029** · — · ACTIVE_NOT_RECRUITING · sponsor: **United Therapeutics** · enrollment: 300 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Oral treprostinil

## Key facts

- **NCT ID:** NCT03045029
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-18
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03045029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03045029, "ADAPT - A Patient Registry of the Real-world Use of Orenitram®". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03045029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*